| Year |
Citation |
Score |
| 2018 |
Meyer AM, Tippett DC, Turner RS, Friedman RB. Long-Term maintenance of anomia treatment effects in primary progressive aphasia. Neuropsychological Rehabilitation. 1-25. PMID 29380657 DOI: 10.1080/09602011.2018.1425146 |
0.333 |
|
| 2013 |
Meyer A, Getz H, Snider S, Sullivan K, Long S, Turner R, Friedman R. Remediation and Prophylaxis of Anomia in Primary Progressive Aphasia. Procedia, Social and Behavioral Sciences. 94: 275-276. PMID 25101147 DOI: 10.1016/j.sbspro.2013.09.138 |
0.358 |
|
| 2004 |
King GD, Cherian K, Turner RS. X11alpha impairs gamma- but not beta-cleavage of amyloid precursor protein. Journal of Neurochemistry. 88: 971-82. PMID 14756819 DOI: 10.1046/J.1471-4159.2003.02234.X |
0.548 |
|
| 2003 |
King GD, Perez RG, Steinhilb ML, Gaut JR, Turner RS. X11alpha modulates secretory and endocytic trafficking and metabolism of amyloid precursor protein: mutational analysis of the YENPTY sequence. Neuroscience. 120: 143-54. PMID 12849748 DOI: 10.1016/S0306-4522(03)00284-7 |
0.524 |
|
| 1996 |
Turner RS, Kenyon LC, Trojanowski JQ, Gonatas N, Grossman M. Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Annals of Neurology. 39: 166-73. PMID 8967747 DOI: 10.1002/Ana.410390205 |
0.631 |
|
| 1996 |
Cook DG, Turner RS, Kolson DL, Lee VM, Doms RW. Vaccinia virus serves as an efficient vector for expressing heterologous proteins in human NTera 2 neurons. The Journal of Comparative Neurology. 374: 481-92. PMID 8910730 DOI: 10.1002/(Sici)1096-9861(19961028)374:4<481::Aid-Cne1>3.0.Co;2-Y |
0.341 |
|
| 1996 |
Turner RS, Suzuki N, Chyung AS, Younkin SG, Lee VM. Amyloids beta40 and beta42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. The Journal of Biological Chemistry. 271: 8966-70. PMID 8621541 DOI: 10.1074/Jbc.271.15.8966 |
0.389 |
|
| 1993 |
Wertkin AM, Turner RS, Pleasure SJ, Golde TE, Younkin SG, Trojanowski JQ, Lee VM. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proceedings of the National Academy of Sciences of the United States of America. 90: 9513-7. PMID 8415732 DOI: 10.1073/Pnas.90.20.9513 |
0.61 |
|
| 1986 |
Kuo JF, Shoji M, Girard PR, Mazzei GJ, Turner RS, Su HD. Phospholipid/calcium-dependent protein kinase (protein kinase C) system: a major site of bioregulation. Advances in Enzyme Regulation. 25: 387-400. PMID 2433906 |
0.511 |
|
| 1986 |
Su HD, Kemp BE, Turner RS, Kuo JF. Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C). Biochemical and Biophysical Research Communications. 134: 78-84. PMID 2418828 |
0.536 |
|
| 1985 |
Turner RS, Kemp BE, Su HD, Kuo JF. Substrate specificity of phospholipid/Ca2+-dependent protein kinase as probed with synthetic peptide fragments of the bovine myelin basic protein. The Journal of Biological Chemistry. 260: 11503-7. PMID 2413012 |
0.521 |
|
| 1984 |
Qi DF, Turner RS, Kuo JF. S-100 and other acidic proteins promote Ca2+-independent phosphorylation of protamine catalyzed by a new protein kinase from brain. Journal of Neurochemistry. 42: 458-65. PMID 6693880 |
0.549 |
|
| 1984 |
Mazzei GJ, Schatzman RC, Turner RS, Vogler WR, Kuo JF. Phospholipid-sensitive Ca2+-dependent protein kinase inhibition by R-24571, a calmodulin antagonist. Biochemical Pharmacology. 33: 125-30. PMID 6584106 |
0.51 |
|
| 1984 |
Turner RS, Raynor RL, Mazzei GJ, Girard PR, Kuo JF. Developmental studies of phospholipid-sensitive Ca2+-dependent protein kinase and its substrates and of phosphoprotein phosphatases in rat brain. Proceedings of the National Academy of Sciences of the United States of America. 81: 3143-7. PMID 6328500 |
0.526 |
|
| 1984 |
Turner RS, Chou CH, Mazzei GJ, Dembure P, Kuo JF. Phospholipid-sensitive Ca2+ -dependent protein kinase preferentially phosphorylates serine-115 of bovine myelin basic protein. Journal of Neurochemistry. 43: 1257-64. PMID 6208326 |
0.546 |
|
| 1984 |
Kuo JF, Schatzman RC, Turner RS, Mazzei GJ. Phospholipid-sensitive Ca2+-dependent protein kinase: a major protein phosphorylation system. Molecular and Cellular Endocrinology. 35: 65-73. PMID 6203790 |
0.536 |
|
| 1983 |
Mazzei GJ, Qi DF, Schatzman RC, Raynor RL, Turner RS, Kuo JF. Comparative abilities of lanthanide ions La3+ and Tb3+ to substitute for Ca2+ in regulating phospholipid-sensitive Ca2+-dependent protein kinase and myosin light chain kinase. Life Sciences. 33: 119-29. PMID 6688112 |
0.511 |
|
| 1983 |
Qi DF, Schatzman RC, Mazzei GJ, Turner RS, Raynor RL, Liao S, Kuo JF. Polyamines inhibit phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases. The Biochemical Journal. 213: 281-8. PMID 6615435 DOI: 10.1042/bj2130281 |
0.543 |
|
| 1983 |
Kuo JF, Raynor RL, Mazzei GJ, Schatzman RC, Turner RS, Kem WR. Cobra polypeptide cytotoxin I and marine worm polypeptide cytotoxin A-IV are potent and selective inhibitors of phospholipid-sensitive Ca2+-dependent protein kinase. Febs Letters. 153: 183-6. PMID 6298006 DOI: 10.1016/0014-5793(83)80144-6 |
0.537 |
|
| 1982 |
Wise BC, Glass DB, Chou CH, Raynor RL, Katoh N, Schatzman RC, Turner RS, Kibler RF, Kuo JF. Phospholipid-sensitive Ca2+-dependent protein kinase from heart. II. Substrate specificity and inhibition by various agents. The Journal of Biological Chemistry. 257: 8489-95. PMID 7085679 |
0.512 |
|
| 1982 |
Katoh N, Raynor RL, Wise BC, Schatzman RC, Turner RS, Helfman DM, Fain JN, Kuo JF. Inhibition by melittin of phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases. The Biochemical Journal. 202: 217-24. PMID 6896276 |
0.547 |
|
| 1982 |
Turner RS, Chou CH, Kibler RF, Kuo JF. Basic protein in brain myelin is phosphorylated by endogenous phospholipid-sensitive Ca2+-dependent protein kinase. Journal of Neurochemistry. 39: 1397-404. PMID 6181205 |
0.544 |
|
| Show low-probability matches. |